Diagnostics, digital pathology AI, and governed clinical software
Authorised Aiforia digital pathology AI. Privexa-built protected AI products. A broader diagnostic pipeline for New Zealand healthcare. All connected through Translyx's clinical technology platform.
Portfolio overview
One clinical technology company. Multiple governed products. One diagnostic mission.
Translyx connects authorised partner solutions, Privexa-built protected AI products, and a diagnostic technology pipeline — all positioned for clinical adoption in New Zealand and Oceania.
Aiforia Digital Pathology AI
AI-assisted digital pathology workflows for clinical, preclinical, and research applications — including Aiforia Clinical Suites and Aiforia Create Platform.
Privexa AI Wrapper
A secure LLM gateway that intercepts and replaces sensitive data with safe tokens before any message reaches an AI system. Responses are restored with original context automatically.
Privexa Cloud Shield
Field-level tokenisation for cloud data pipelines. Sensitive fields are replaced before reaching cloud platforms — the local mapping vault is reversible only inside your perimeter.
Privexa Scribe
Clinical consultation recording with full PHI protection. Record, transcribe, and generate clinician-ready notes — sensitive data never leaves your boundary.
Privexa Trace
Reviewer-gated synthetic control arm workflows with manual benchmark comparison, lineage, visible limitations, and submission-oriented packaging.
ClinicalTriage
Audited clinical pathway and referral grading support with role-based access, specialist review, and full audit trail. Designed for authorised clinical users.
Clinical & Diagnostic Pipeline
Advanced diagnostic technologies for New Zealand healthcare — antimicrobial resistance, sepsis, point-of-care testing, oncology biomarkers, endocrinology, cardiac markers, and precision medicine.
Privexa-built software, delivered through a clinical technology lens
Translyx works with Privexa Limited to bring protected AI software into clinical and diagnostic workflows. Privexa builds the software; Translyx focuses on clinical positioning and healthcare adoption.
Product ecosystem
Diagnostics, digital pathology AI, and governed software — connected for clinical impact
Translyx brings clinical technology into healthcare settings. Privexa builds the privacy-first software products that power those workflows.
Clinical technology company
Translyx Limited
Clinical technology, diagnostics, and healthcare adoption · Auckland, New Zealand
Authorised partner
Aiforia Digital Pathology AI
AI-assisted digital pathology for clinical, preclinical, and research workflows.
Built by Privexa
Privexa-Built AI Products
Privacy-first AI software for healthcare workflows — clinically positioned through Translyx.
Diagnostic portfolio
Clinical & Diagnostic Pipeline
AMR, sepsis, POCT, oncology, endocrine, cardiac, and precision medicine for New Zealand.
Translyx focuses on clinical positioning, diagnostic adoption, and local partnerships. Privexa builds the protected AI software layer. Together, they connect diagnostics, digital pathology AI, and governed software for regulated clinical environments.
Speak with Translyx about your clinical technology priorities
Request a walkthrough to see Aiforia digital pathology AI, Privexa-built data protection and evidence workflows, and the broader Translyx diagnostic portfolio in context.